/Investor DB

Boomerang Ventures — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

ADHD Onlineadhdonline.comin𝕏Jul 2023 · $12M

ADHD Online provides virtual ADHD assessment, diagnosis, and treatment for adults, offering clinically validated diagnostic evaluations reviewed by licensed clinical psychologists and follow-up telehealth appointments with board-certified clinicians for prescriptions and treatment plans.

Digital HealthHealthtechMental HealthGrand Rapids, US

Randall Duthler(Executive Officer, Director)Christopher Barber(Executive Officer)Zachariah Booker(Executive Officer, Director)

BoardDale Grogan(Director)in

Co-investorsMichigan RiseMichigan Capital NetworkWakestream Ventures

Mentavimentavi.comin𝕏May 2023

Mentavi Health provides clinician-reviewed online diagnostic evaluations that screen for up to 29 mental health conditions, including ADHD, anxiety, depression, and OCD, with results reviewed by licensed doctorate-level psychologists.

Digital HealthHealthtechMental HealthGrand Rapids, US

Keith Brophy(Chief Executive Officer)inDave Peralta(Chief Financial Officer)inDr. Barry K. Herman(Chief Medical Officer)Angie Lillie(Chief Compliance Officer)inSteve Goulet(VP of Technology and Product)inRandall Duthler(Director)

Co-investorsInvest MichiganMichigan Capital NetworkWakestream Ventures

Xploroxploro.healthDec 2023

Xploro is a pediatric digital health company whose platform uses AR, games and an AI avatar to prepare children for hospital treatment.

Co-investorsGC AngelsJumpstart VenturesUCeed Funds

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.